SpicyIP Weekly Review (November 25 – December 1)
Here is our recap of last week’s top IP developments including summaries of the posts on IPO’s patent application rejection of HIV drug Dolutegravir, another judgement in the long-running Section 3(k) saga, this time on the patentability of business methods and the DHC IPD’s Annual Report 2023-24. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week SpicyIP Tidbit: Patent Office […]
SpicyIP Weekly Review (November 25 – December 1) Read More »










